|
HIF1AN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12589999989865E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.39770000004724E-06 |
| Normal-vs-Stage2 |
1.77036999999824E-05 |
| Normal-vs-Stage3 |
2.0735000000327E-06 |
| Normal-vs-Stage4 |
4.32080000001278E-06 |
| Stage1-vs-Stage2 |
2.919800E-01 |
| Stage1-vs-Stage3 |
3.613600E-01 |
| Stage1-vs-Stage4 |
3.034800E-01 |
| Stage2-vs-Stage3 |
7.265000E-01 |
| Stage2-vs-Stage4 |
9.588000E-01 |
| Stage3-vs-Stage4 |
7.586600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.66729999975901E-07 |
| Normal-vs-AfricanAmerican |
1.000100E-02 |
| Normal-vs-Asian |
5.199100E-03 |
| Caucasian-vs-AfricanAmerican |
5.946000E-01 |
| Caucasian-vs-Asian |
2.261000E-01 |
| AfricanAmerican-vs-Asian |
7.410000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.50660000533642E-08 |
| Normal-vs-Female |
1.56120000005533E-06 |
| Male-vs-Female |
8.114400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.33469999999914E-05 |
| Normal-vs-Age(41-60Yrs) |
6.40739999946405E-07 |
| Normal-vs-Age(61-80Yrs) |
3.34099999999005E-07 |
| Normal-vs-Age(81-100Yrs) |
1.110320E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.761600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.490370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.035600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.530400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.762400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.869200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.273600E-01 |
| Classical-VS-Follicular |
9.559800E-04 |
| Classical-VS-Other |
1.560190E-01 |
| Classical-VS-Normal |
1.92683999999943E-05 |
| Tall-VS-Follicular |
9.173600E-02 |
| Tall-VS-Other |
2.664400E-01 |
| Tall-VS-Normal |
3.361500E-03 |
| Follicular-VS-Other |
9.065400E-01 |
| Follicular-VS-Normal |
6.02849999919997E-08 |
| Other-VS-Normal |
8.078100E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.87269999951667E-07 |
| Normal-vs-N1 |
4.59379999995235E-06 |
| N0-vs-N1 |
5.453400E-01 |
|
|
